Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.

Number of the records: 1

1.

SYSNO	0580702
Title	Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.
Author(s)	Kovář, Marek (MBU-M)_{RID, ORCID} Šubr, Vladimír (UMCH-V) [BIOMOL]_{RID, ORCID} Běhalová, Kateřina (MBU-M) Studenovský, Martin (UMCH-V) [BIOMOL]_{RID, ORCID} Starenko, Daniil (MBU-M) Kovářová, Jiřina (MBU-M) Procházková, Petra (MBU-M)_{RID, ORCID} Etrych, Tomáš (UMCH-V) [BIOMOL]_{RID, ORCID} Kostka, Libor (UMCH-V) [BIOMOL]_{RID, ORCID}
Corespondence/senior	Kostka, Libor - Korespondující autor
Source Title	Nanomedicine: Nanotechnology, Biology and Medicine. Roč. 56, February 2024 (2024), s. 102730. - : Elsevier
Document Type	Článek v odborném periodiku
Grant	NU21-03-00273 GA MZd - Ministry of Health (MZ), CZ - Czech Republic
	LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
Institutional support	MBU-M - RVO:61388971 ; UMCH-V - RVO:61389013
Language	eng
Country	NL
Keywords	STAT3 inhibitor * Doxorubicin * HPMA copolymer carrier * pH-sensitive drug * release
URL	https://www.sciencedirect.com/science/article/pii/S1549963423000813
Permanent Link	https://hdl.handle.net/11104/0349459

	File	Download	Size	Commentary	Version	Access
	0580702.pdf	1	5 MB	CC BY license	Publisher’s postprint	open-access
	Kovar et al_Nanomedicine.pdf	0	5 MB		Publisher’s postprint	open-access

Number of the records: 1